Search results

Modified component of green tea promises potential neuroblastoma treatment.

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Australia’s best known carnivorous dinosaur Australovenator is under the microscope at ANSTO

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.

Aimed at those working predominantly with unsealed radioactive sources, typically in a research, radiopharmaceutical or hospital environment

Aimed at those working with fixed radiation gauges incorporating gamma or neutron sources, portable moisture/density gauges, and borehole logging equipment incorporating radiation sources

Minister for Industry and Science, the Hon Ed Husic MP has formally announced the appointment of Mr Andrew Carriline as ANSTO Board Deputy Chairperson, effective from Thursday 9 May 2024.

Accelerator technique used in pioneering biomaterials research led by the University of Sydney.

ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.

General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop

Researchers have discovered a 380-million-year-old heart – the oldest ever found – alongside a separate fossilised stomach, intestine and liver in an ancient jawed fish, shedding new light on the evolution of our own bodies.

The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.